Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Recurrence 1Peritoneal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Immunologic Deficiency Syndromes 1Glioblastoma 1Genital Neoplasms, Female 1Fallopian Tube Neoplasms 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Adenoviridae Infections 1Abdominal Neoplasms 1

Interventions

Standard of Care 2Methods 2Interviews as Topic 2Educational Status 2Early Intervention, Educational 2relacorilant 1nilotinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Therapeutic Touch 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy 1Pregnancy Tests 1Practice Guidelines as Topic 1Paclitaxel 1Nivolumab 1Laparoscopy 1Ipilimumab 1Human Papillomavirus DNA Tests 1Fulvestrant 1Electrocardiography 1Colposcopy 1Cell Count 1Biopsy 1Bevacizumab 1Behavior Therapy 1Acetic Acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Cell Count × 1 year × Clear all
NCT05617755 2025-07-30

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

Arsenal Biosciences, Inc.

Phase 1 Active not recruiting
19 enrolled
Gynecologic

Abdominal Neoplasms, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡